Cargando…

C-Type Lectin-Like Molecule-1 as a Biomarker for Diagnosis and Prognosis in Acute Myeloid Leukemia: A Preliminary Study

OBJECTIVE: AML is a heterogeneous disease both in genomic and proteomic backgrounds, and variable outcomes may appear in the same cytogenetic risk group. Therefore, it is still necessary to identify new antigens that contribute to diagnostic information and to refine the current risk stratification....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jinghua, Wang, Weida, Chen, Hao, Li, Wenmin, Huang, Tian, Zhang, Weiya, Ling, Wei, Lai, Peilong, Wang, Yulian, Geng, Suxia, Li, Minming, Du, Xin, Weng, Jianyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979301/ https://www.ncbi.nlm.nih.gov/pubmed/33778076 http://dx.doi.org/10.1155/2021/6643948

Ejemplares similares

Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia
por: Wang, Jinghua, et al.
Publicado: (2022)

Dynamics of PD-1 expression are associated with treatment efficacy and prognosis in patients with intermediate/high-risk myelodysplastic syndromes under hypomethylating treatment
por: Geng, Suxia, et al.
Publicado: (2022)

Deep learning-based transcriptome model predicts survival of T-cell acute lymphoblastic leukemia
por: Zhang, Lenghe, et al.
Publicado: (2022)

C3aR costimulation enhances the antitumor efficacy of CAR-T cell therapy through Th17 expansion and memory T cell induction
por: Lai, Peilong, et al.
Publicado: (2022)

Analysis of the expression of PHTF1 and related genes in acute lymphoblastic leukemia
por: Huang, Xin, et al.
Publicado: (2015)

The Gut Bacteria Dysbiosis Contributes to Chronic Graft-Versus-Host Disease Associated With a Treg/Th1 Ratio Imbalance
por: Wang, Yulian, et al.
Publicado: (2022)

Alternative expression of TCRζ related genes in patients with chronic myeloid leukemia
por: Zha, Xianfeng, et al.
Publicado: (2012)

Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway
por: Xu, Ruohao, et al.
Publicado: (2023)

Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia
por: Laborda, Eduardo, et al.
Publicado: (2017)

Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg
por: Wang, Yulian, et al.
Publicado: (2017)

A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia
por: Weng, Jianyu, et al.
Publicado: (2018)

Correction to: A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia
por: Weng, Jianyu, et al.
Publicado: (2019)

Mutational spectrum and prognosis in NRAS-mutated acute myeloid leukemia
por: Wang, Shujuan, et al.
Publicado: (2020)

Adhesion molecules in acute myeloid leukemia()
por: Paietta, Elisabeth
Publicado: (1996)

A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD
por: Lai, Peilong, et al.
Publicado: (2018)

Phenotype of mesenchymal stem cells from patients with myelodyplastic syndrome maybe partly modulated by decitabine
por: Pang, Yanbin, et al.
Publicado: (2019)

CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
por: Wang, Jinghua, et al.
Publicado: (2018)

Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome
por: Huang, Xin, et al.
Publicado: (2021)

Targets preliminary screening for the fresh natural drug molecule based on Cosine-correlation and similarity-comparison of local network
por: Zhao, Pengcheng, et al.
Publicado: (2022)

Decitabine With or Without Micro-Transplantation for the Treatment of Intermediate or High-Risk Myelodysplastic Syndrome: A Chinese Single-Center Retrospective Study of 22 Patients
por: Li, MinMing, et al.
Publicado: (2021)

Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia
por: Li, Guilan, et al.
Publicado: (2020)

Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia
por: Chen, Si-Liang, et al.
Publicado: (2020)

Karyotype complexity and prognosis in acute myeloid leukemia
por: Stölzel, F, et al.
Publicado: (2016)

Cytogenetics’ impact on the prognosis of acute myeloid leukemia
por: Gupta, Monika, et al.
Publicado: (2019)

Monocytic Myeloid-Derived Suppressor Cells But Not Monocytes Predict Poor Prognosis of Acute Myeloid Leukemia
por: Ren, Xiyang, et al.
Publicado: (2022)

Circulating Monocytic Myeloid-Derived Suppressor Cells Are Elevated and Associated with Poor Prognosis in Acute Myeloid Leukemia
por: Wang, Huiping, et al.
Publicado: (2020)

Mechanisms of Resistance to Small Molecules in Acute Myeloid Leukemia
por: Lang, Tonio Johannes Lukas, et al.
Publicado: (2023)

DLC1 deficiency at diagnosis predicts poor prognosis in acute myeloid leukemia
por: Li, Xueqian, et al.
Publicado: (2022)

Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI
por: Xu, Ling, et al.
Publicado: (2016)

A three-lncRNA signature for prognosis prediction of acute myeloid leukemia in patients
por: Wang, Fangce, et al.
Publicado: (2018)

Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis
por: Li, Shufen, et al.
Publicado: (2017)

Poor Prognosis in Acute Myeloid Leukemia Patients with Monosomal Karyotypes
por: Xu, Junqing, et al.
Publicado: (2017)

Immune‐relatedlncRNAs can predict the prognosis of acute myeloid leukemia
por: Li, Ran, et al.
Publicado: (2021)

ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemia
por: Li, Ran, et al.
Publicado: (2022)

Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia
por: Wang, Jinghan, et al.
Publicado: (2019)

High expression of DOCK2 indicates good prognosis in acute myeloid leukemia
por: Hu, Ning, et al.
Publicado: (2019)

Enhanced MCM5 Level Predicts Bad Prognosis in Acute Myeloid Leukemia
por: Wang, Shuming, et al.
Publicado: (2022)

Acute Myeloid Leukemia—Genetic Alterations and Their Clinical Prognosis
por: Lagunas-Rangel, Francisco Alejandro, et al.
Publicado: (2017)

Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives
por: Russo, Domenico, et al.
Publicado: (2020)

Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia
por: Wu, Zhengwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gu1r3ij8fqk1isg9bhn4o9qb36